Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to ...

Roche has taken its worldwide collaboration with mySugr to the next level by acquiring the Austrian digital health business. The company has set itself apart from others by trying to balance fun ...

Roche has expanded its partnership with diabetes startup company mySugr following the release of promising real world data. Presented at the International Conference on Advanced Technologies and ...

How did this acquisition happen? The negotiations that led to this deal were intensive and long. It was probably the most interesting but also the most exhausting time for us founders and the ...

Swiss drugmaker Roche has acquired digital diabetes management platform mySugr for an undisclosed sum, making it an integral part of its patient-centered diabetes services strategy, FierceBiotech ...

The crossover among device makers, digital health, and big data continues, as consolidation that some have predicted in the diabetes space is apparent. Roche announced Friday it has acquired mySugr, ...

mySugr, a popular digital diabetes management platform which emerged from Austria a few years ago, has been acquired by health giant Roche. It now becomes the heart of Roche Diabetes Care’s new ...

The deal was confirmed today for an undisclosed fee, but the app already has 1 million users globally, and its price will have reflected its mature business model. The acquisition could be pivotal in ...

Diabetes app maker mySugr, which is based in Austria and the US, raised a few million euros in an investment round led by XL Health and Puspok. Johann Hansmann, an angel investor that has previously ...

The mySugr Bolus Calculator from Roche Diabetes has been recalled due to a serious bug. mySugr Bolus Calculator is intended to help users determine the insulin dose they require. It is available for ...